Tikaglor 90 Tablet
Marketer
Care Formulation Labs Pvt Ltd
Salt Composition
Ticagrelor (90mg)
Overview Tikaglor 90 Tablet
Ticagrelor 90mg tablets are antiplatelet agents, also known as blood thinners. They inhibit the creation of dangerous blood clots within blood vessels, thereby lowering the risk of heart attack or stroke in patients with cardiac conditions. This medication is also indicated for individuals who have recently experienced a heart attack, severe angina (chest pain), or undergone cardiac stenting. Its purpose is to mitigate the likelihood of further cardiac events, including recurrent heart attack, stroke, or stent thrombosis. Concurrent use with aspirin, another antiplatelet drug, is typically prescribed. Ticagrelor 90mg can be administered with or without food, consistently at the same time daily. Consistent use is crucial, even during periods of well-being, as discontinuation elevates the risk of future cardiovascular events. The most prevalent side effect is bleeding, potentially prolonging bleeding time from injuries. While generally mild and self-resolving, persistent or heavy bleeding should be reported. Some patients experience mild shortness of breath, typically subsiding with continued therapy; however, worsening or persistent symptoms warrant medical attention. This medication is contraindicated in individuals with active bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Pre-existing conditions should always be disclosed to your physician before commencing treatment.
Uses of Tikaglor 90 Tablet
Avoiding heart attack and stroke
Major Benefits of Tikaglor 90 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Tikaglor 90 Tablet whole; do not crush, chew, or break it. While it can be taken with or without food, consistency is key – take it at the same time each day.
Common Side effects of Tikaglor 90 Tablet:
- Bleeding
- Breathlessness
How to use Tikaglor 90 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tikaglor 90 Tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended.
How Tikaglor 90 Tablet works:
Brilinta 90 mg tablets are a type of antiplatelet drug. Their mechanism of action involves inhibiting platelet aggregation, thus reducing the risk of dangerous blood clot development. This, in turn, minimizes the likelihood of experiencing a heart attack or stroke.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Tikaglor 90 Tablet and alcohol. Seek your physician's advice.
PregnancyCONSULT YOUR DOCTOR
Using Tikaglor 90mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on Tikaglor 90 Tablet use while breastfeeding is absent. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Tikaglor 90 mg tablets.
KidneySAFE IF PRESCRIBED
Ticagrelor 90 mg tablets are considered safe for individuals with kidney impairment; dosage modification is not typically necessary. Data regarding ticagrelor 90 mg tablet use in patients undergoing renal dialysis remains limited.
LiverCAUTION
Patients with liver impairment should use Ticagrelor 90 mg tablets cautiously, potentially requiring dose modification. Severe hepatic dysfunction contraindicates the use of Ticagrelor 90 mg tablets; physician consultation is advised.
What if you forget to take Tikaglor 90 Tablet :
Should you forget a Tikaglor 90 Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Tikaglor 90 Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |




